Sangamo Therapeutics (0R1D.LSE) Q3 2024 Earnings

6AugConfirmed
Q2 2024
Q3 2024
-0.27
-0.23
-0.19
-0.15

Details

Expected EPS
-0.146729
Actual EPS
-0.18
Surprise EPS
-0.03
Surprise Percent
+22.68%

Description

Sangamo Therapeutics (0R1D.LSE) has reported earnings of -0.18 per share for Q3 2024.

0 Comments

Share your thoughts